Influenza in long-term care facilities

Influenza and other Respiratory Viruses

Volumn 11, Issue 5, 2017, Pages 356-366

  Lansbury, Louise E ^a   Brown, Caroline S ^b   Nguyen Van Tam, Jonathan S ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b WHO REGIONAL OFFICE FOR EUROPE   (Denmark)

Author keywords

antivirals; infection control; influenza; long term care; vaccines

Indexed keywords

INFLUENZA VACCINE; OSELTAMIVIR; ZANAMIVIR; ANTIVIRUS AGENT;

CLINICAL PRACTICE; DISEASE CONTROL; DISEASE SURVEILLANCE; DRUG EFFECT; DRUG EFFICACY; EARLY DIAGNOSIS; EPIDEMIC; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HUMAN; LONG TERM CARE; MEDICAL EDUCATION; NOTE; PREVENTION AND CONTROL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEASONAL INFLUENZA; VACCINATION; VIRUS CULTURE; AGED; FEMALE; INFECTION CONTROL; INFLUENZA; ISOLATION AND PURIFICATION; MALE; NURSING HOME; ORTHOMYXOVIRIDAE; PHYSIOLOGY; SEASON; VIROLOGY; WORLD HEALTH ORGANIZATION;

AGED; ANTIVIRAL AGENTS; DISEASE OUTBREAKS; FEMALE; HUMANS; INFECTION CONTROL; INFLUENZA VACCINES; INFLUENZA, HUMAN; LONG-TERM CARE; MALE; NURSING HOMES; ORTHOMYXOVIRIDAE; SEASONS; VACCINATION; WORLD HEALTH ORGANIZATION;

EID: 85029477510     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12464     Document Type: Note

References (126)

1. Organisation for Economic Co-operation and Development. OECD Health Statistics 2016. Definitions, sources and methods. June 2016.
2. World Health Organization. World Report on Ageing and Health. Geneva: World Health Organization; 2015.
3. Centers for Disease Control and Prevention. Interim Guidance for Influenza Outbreak Management in Long-Term Care Facilities. Available from: http://www.cdc.gov/flu/professionals/infectioncontrol/ltc-facility-guidance.htm. Accessed Arch 15, 2016.
4. Public Health England. PHE guidelines on the management of outbreaks of influenza-like illness (ILI) in care homes. 2016 Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/573143/ILI_in_care_homes_291116.pdf. Accessed January 10, 2017.
5. Public Health Medicine Communicable Disease Group. Public Health Guidelines on the Prevention and Management of Influenza Outbreaks in Residential Care Facilities in Ireland 2015/2016. Version 1.8. Health Service Executive; Available from: https://www.hpsc.ie/a-z/respiratory/influenza/seasonalinfluenza/guidance/residentialcarefacilitiesguidance/File,13195,en.pdf Accessed February 21, 2016.
6. Haute Conseil de la Santé Publique. Conduite à tenir devant une ou plusieurs infections respiratoires aiguës dans les collectivités de personnes âgées. Juillet 2012. Available from: http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=288. Accessed February 16, 2016.
7. Robert Koch Institut. Empfehlungen des Robert Koch- Institutes zu Präventions- und Kontrollmaßnahmen bei Bewohnern mit Verdacht auf bzw. nachgewiesener Influenza in Heimen. August 2010. Available from: http://www.rki.de/DE/Content/Infekt/Krankenhaushygiene/Erreger_ausgewaehlt/Influenza/Influenza_Heim_pdf.pdf?__blob=publicationFile Accessed February 16, 2016.
8. Cools HJ. Practice guideline ‘Influenza prevention in nursing homes and care homes’, issued by the Dutch Society of Nursing Home Specialists. Ned Tijdschr Geneeskd. 2005;149:213.
9. Nacionalni inštitut za javno zdrave. Guidance for management of influenza outbreaks in long-term care facilities 2015. Available from: wwww.NIJZ.si/področja/Nalezljive bolezni/Gradiva. Accessed February 3, 2016.
10. Public Health Agency of Canada. Guidance: Infection Prevention and Control Measures for Healthcare Workers in Acute Care and Long-term Care Settings – Seasonal Influenza. Available from: http://www.phac-aspc.gc.ca/nois-sinp/guide/ac-sa-eng.php. Accessed December 6, 2016.
11. Communicable Diseases Network Australia. A Practical Guide to Assist in the Prevention and Management of Influenza Outbreaks in Residential Care Facilities in Australia. 2009. Available from: http://www.hnehealth.nsw.gov.au/hneph/disease%20outbreaks/Documents/flu-prevention-guidelines.pdf Accessed December 16, 2016.
12. World Health Organization Regional Office for Europe. Prevention and control of outbreaks of seasonal influenza in long-term care facilities: a review of the evidence and best practice guidance. 2017. Available from: http://www.euro.who.int/__data/assets/pdf_file/0015/330225/LTCF-best-practice-guidance.pdf?ua=1. Accessed April 6, 2017.
13. Pop-Vicas A, Gravenstein S. Influenza in the elderly: a mini-review. Gerontology. 2011;57:397-404.
14. Strausbaugh LJ, Sukumar SR, Joseph CL. Infectious disease outbreaks in nursing homes: an unappreciated hazard for frail elderly persons. Clin Infect Dis. 2003;36:870-876.
15. Drinka PJ, Krause P, Nest L, et al. Delays in the application of outbreak control prophylaxis for influenza A in a nursing home. Infect Control Hosp Epidemiol. 2002;23:600-603.
16. Ellis SE, Coffey CS, Mitchel EF Jr, Dittus RS, Griffin MR. Influenza- and respiratory syncytial virus-associated morbidity and mortality in the nursing home population. J Am Geriatr Soc. 2003;51:761-767.
17. Utsumi M, Makimoto K, Quroshi N, Ashida N. Types of infectious outbreaks and their impact in elderly care facilities: a review of the literature. Age Ageing. 2010;39:299-305.
18. Gaillat J, Chidiac C, Fagnani F, et al. Morbidity and mortality associated with influenza exposure in long-term care facilities for dependent elderly people. Eur J Clin Microbiol Infect Dis. 2009;28:1077-1086.
19. Mertz D, Kim TH, Johnstone J, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ. 2013;347:f5061.
20. Matias G, Taylor RJ, Haguinet F, et al. Modelling estimates of age-specific influenza-related hospitalisation and mortality in the United Kingdom. BMC Public Health. 2016;16:481.
21. Fleming D, Harcourt S, Smith G. Influenza and adult hospital admissions for respiratory conditions in England 1989-2001. Commun Dis Public Health. 2003;6:231-237.
22. Finkelman BS, Viboud C, Koelle K, et al. Global patterns in seasonal activity of influenza A/H3N2, A/H1N1, and B from 1997 to 2005: viral coexistence and latitudinal gradients. PLoS One. 2007;2:e1296.
23. van der Sande MAB, Ruijs WLM, Meijer A, Cools HJM, van der Plas SM. Use of oseltamivir in Dutch nursing homes during the 2004-2005 influenza season. Vaccine. 2006;24:6664-6669.
24. Kohn MA, Farley TA, Sundin D, et al. Three summertime outbreaks of influenza type A. J Infect Dis. 1995;172:246-249.
25. Gralton J, Tovey E, McLaws ML, Rawlinson WD. The role of particle size in aerosolised pathogen transmission: a review. J Infect. 2011;62:1-13.
26. Milton DK, Fabian MP, Cowling BJ, Grantham ML, McDevitt JJ. Influenza virus aerosols in human exhaled breath: particle size, culturability, and effect of surgical masks. PLoS Pathog. 2013;9:e1003205.
27. Fabian P, McDevitt JJ, DeHaan WH, et al. Influenza virus in human exhaled breath: an observational study. PLoS One. 2008;3:e2691.
28. Lindsley WG, Noti JD, Blachere FM, et al. Viable influenza A virus in airborne particles from human coughs. J Occup Environ Hyg. 2015;12:107-113.
29. Bischoff WE, Swett K, Leng I, Peters TR. Exposure to influenza virus aerosols during routine patient care. J Infect Dis. 2013;207:1037-1046.
30. Brankston G, Gitterman L, Hirji Z, Lemieux C, Gardam M. Transmission of influenza A in human beings. Lancet Infect Dis. 2007;7:257-265.
31. Seto WH. Airborne transmission and precautions: facts and myths. J Hosp Infect. 2015;89:225-228.
32. Killingley B, Nguyen-Van-Tam J. Routes of influenza transmission. Influenza Other Respir Viruses. 2013;7(suppl 2):42-51.
33. Thomas RE. Do we have enough evidence how seasonal influenza is transmitted and can be prevented in hospitals to implement a comprehensive policy? Vaccine. 2016;34:3014-3021.
34. Carrat F, Vergu E, Ferguson NM, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol. 2008;167:775-785.
35. Vink MA, Bootsma MC, Wallinga J. Serial intervals of respiratory infectious diseases: a systematic review and analysis. Am J Epidemiol. 2014;180:865-875.
36. Bell D, Nicoll A, Fukuda K, et al. Non-pharmaceutical interventions for pandemic influenza, international measures. Emerg Infect Dis. 2006;12:81-87.
37. Lau LL, Ip DK, Nishiura H, et al. Heterogeneity in viral shedding among individuals with medically attended influenza A virus infection. J Infect Dis. 2013;207:1281-1285.
38. Tsang TK, Cowling BJ, Fang VJ, et al. Influenza A virus shedding and infectivity in households. J Infect Dis. 2015;212:1420-1428.
39. Tsang TK, Fang VJ, Chan KH, et al. Individual correlates of infectivity of influenza A virus infections in households. PLoS One. 2016;11:e0154418.
40. Suess T, Remschmidt C, Schink SB, et al. Comparison of shedding characteristics of seasonal influenza virus (sub)types and influenza A(H1N1)pdm09; Germany, 2007-2011. PLoS One. 2012;7:e51653.
41. Ip DK, Lau LL, Chan KH, et al. The dynamic relationship between clinical symptomatology and viral shedding in naturally acquired seasonal and pandemic influenza virus infections. Clin Infect Dis. 2016;62:431-437.
42. Loeb M, Singh PK, Fox J, et al. Longitudinal study of influenza molecular viral shedding in Hutterite communities. J Infect Dis. 2012;206:1078-1084.
43. Cowling BJ, Chan KH, Peiris JS, Riley S, Leung GM. Viral shedding, clinical history and transmission of influenza. Hong Kong Med J. 2013;19(suppl 4):19-23.
44. Frank AL, Taber LH, Wells CR, et al. Patterns of shedding of myxoviruses and paramyxoviruses in children. J Infect Dis. 1981;144:433-441.
45. Hall CB, Douglas RG Jr, Geiman JM, Meagher MP. Viral shedding patterns of children with influenza B infection. J Infect Dis. 1979;140:610-613.
46. Lee N, Chan PK, Hui DS, et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis. 2009;200:492-500.
47. Memoli MJ, Athota R, Reed S, et al. The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts. Clin Infect Dis. 2014;58:214-224.
48. Boivin G, Goyette N, Bernatchez H. Prolonged excretion of amantadine-resistant influenza a virus quasi species after cessation of antiviral therapy in an immunocompromised patient. Clin Infect Dis. 2002;34:E23-E25.
49. Klimov AI, Rocha E, Hayden FG, et al. Prolonged shedding of amantadine-resistant influenza A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis. J Infect Dis. 1995;172:1352-1355.
50. Eibach D, Casalegno JS, Bouscambert M, et al. Routes of transmission during a nosocomial influenza A (H3N2) outbreak among geriatric patients and healthcare workers. J Hosp Infect. 2014;86:188-193.
51. Pagani L, Thomas Y, Huttner B, et al. Transmission and effect of multiple clusters of seasonal influenza in a Swiss geriatric hospital. J Am Geriatr Soc. 2015;63:739-744.
52. Oguma T, Saito R, Masaki H, et al. Molecular characteristics of outbreaks of nosocomial infection with influenza A/H3N2 virus variants. Infect Control Hosp Epidemiol. 2011;32:267-275.
53. Voirin N, Payet C, Barrat A, et al. Combining high-resolution contact data with virological data to investigate influenza transmission in a tertiary care hospital. Infect Control Hosp Epidemiol. 2015;36:254-260.
54. Carnicer-Pont D, White D, Pike C, Lyons M. Influenza A outbreak in a community hospital in south east Wales, February 2005. Euro Surveill. 2005;10:E050217.2.
55. Poland GA, Tosh P, Jacobson RM. Requiring influenza vaccination for health care workers: seven truths we must accept. Vaccine. 2005;23:2251-2255.
56. Kuster SP, Shah PS, Coleman BL, et al. Incidence of influenza in healthy adults and healthcare workers: a systematic review and meta-analysis. PLoS One. 2011;6:e26239.
57. Elder AG, O'Donnell B, McCruden EA, Symington IS, Carman WF. Incidence and recall of influenza in a cohort of Glasgow healthcare workers during the 1993-4 epidemic: results of serum testing and questionnaire. BMJ. 1996;313:1241-1242.
58. Jena AB, Baldwin DC Jr, Daugherty SR, Meltzer DO, Arora VM. Presenteeism among resident physicians. JAMA. 2010;304:1166-1168.
59. Weingarten S, Riedinger M, Bolton LB, Miles P, Ault M. Barriers to influenza vaccine acceptance. A survey of physicians and nurses. Am J Infect Control. 1989;17:202-207.
60. Lester RT, McGeer A, Tomlinson G, Detsky AS. Use of, effectiveness of, and attitudes regarding influenza vaccine among house staff. Infect Control Hosp Epidemiol. 2003;24:839-844.
61. Aronsson G, Gustafsson K, Dallner M. Sick but yet at work. An empirical study of sickness presenteeism. J Epidemiol Community Health. 2000;54:502-509.
62. Yassi A, Bryce E, Moore D, et al. Protecting the Faces of Health Care Workers: Knowledge Gaps and Research Priorities for Effective Protection against Occupationally Acquired Respiratory Infectious Diseases. Report to Change Foundation; April 2004. Available from: http://www1.paho.org/hq/dmdocuments/2009/Protecting%20the%20faces%20of%20health%20care%20workers.pdf. Accessed December 6, 2016.
63. Strategy and action plan for healthy ageing in Europe, 2012-2020. Available from: http://www.euro.who.int/__data/assets/pdf_file/0008/175544/RC62wd10Rev1-Eng.pdf?ua=1. Accessed January 10, 2017.
64. Vaccines against influenza WHO position paper – November 2012. Releve epidemiologique hebdomadaire/Section d'hygiene du Secretariat de la Societe des Nations. Wkly Epidemiol Rec. 2012;87:461-476.
65. European Centre for Disease Prevention and Control. Seasonal Influenza Vaccination in Europe – Overview of Vaccination Recommendations and Coverage Rates in the EU Member States for the 2012-2013 Influenza Season. Stockholm: ECDC; 2015.
66. Jefferson T, Di Pietrantonj C, Al-Ansary LA, et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev. 2010(2):Cd004876.
67. Chan TC, Fan-Ngai Hung I, Ka-Hay Luk J, Chu LW, Hon-Wai Chan F. Effectiveness of influenza vaccination in institutionalized older adults: a systematic review. J Am Med Dir Assoc. 2014;15:226.e1-226.e6.
68. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:36-44.
69. Baxter R, Lee J, Fireman B. Evidence of bias in studies of influenza vaccine effectiveness in elderly patients. J Infect Dis. 2010;201:186-189.
70. Mangtani P, Cumberland P, Hodgson CR, et al. A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. J Infect Dis. 2004;190:1-10.
71. Ridenhour BJ, Campitelli MA, Kwong JC, et al. Effectiveness of inactivated influenza vaccines in preventing influenza-associated deaths and hospitalizations among Ontario residents aged >/= 65 years: estimates with generalized linear models accounting for healthy vaccinee effects. PLoS One. 2013;8:e76318.
72. Thomas RE. Are influenza-associated morbidity and mortality estimates for those >/= 65 in statistical databases accurate, and an appropriate test of influenza vaccine effectiveness? Vaccine. 2014;32:6884-6901.
73. Read CA, Mohsen A, Nguyen-Van-Tam JS, McKendrick M, Kudesia G. Outbreaks of influenza A in nursing homes in Sheffield during the 1997-1998 season: implications for diagnosis and control. J Public Health Med. 2000;22:116-120.
74. Grohskopf LA, Sokolow LZ, Broder KR, et al. Prevention and control of seasonal influenza with vaccines. MMWR Recomm Rep. 2016;65:1-54.
75. Hayward AC, Harling R, Wetten S, et al. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. BMJ. 2006;333:1241.
76. Potter J, Stott DJ, Roberts MA, et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis. 1997;175:1-6.
77. Carman WF, Elder AG, Wallace LA, et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet. 2000;355:93-97.
78. Wendelboe AM, Avery C, Andrade B, Baumbach J, Landen MG. Importance of employee vaccination against influenza in preventing cases in long-term care facilities. Infect Control Hosp Epidemiol. 2011;32:990-997.
79. Lemaitre M, Meret T, Rothan-Tondeur M, et al. Effect of influenza vaccination of nursing home staff on mortality of residents: a cluster-randomized trial. J Am Geriatr Soc. 2009;57:1580-1586.
80. Thomas RE, Jefferson T, Lasserson TJ. Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions. Cochrane Database Syst Rev. 2016(6):Cd005187.
81. Ahmed F, Lindley MC, Allred N, Weinbaum CM, Grohskopf L. Effect of influenza vaccination of healthcare personnel on morbidity and mortality among patients: systematic review and grading of evidence. Clin Infect Dis. 2014;58:50-57.
82. Michiels B, Govaerts F, Remmen R, Vermeire E, Coenen S. A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups. Vaccine. 2011;29:9159-9170.
83. Benet T, Regis C, Voirin N, et al. Influenza vaccination of healthcare workers in acute-care hospitals: a case-control study of its effect on hospital-acquired influenza among patients. BMC Infect Dis. 2012;12:30.
84. Dionne B, Brett M, Culbreath K, Mercier RC. Potential ceiling effect of healthcare worker influenza vaccination on the incidence of nosocomial influenza infection. Infect Control Hosp Epidemiol. 2016;37:840-844.
85. van den Dool C, Bonten MJ, Hak E, Heijne JC, Wallinga J. The effects of influenza vaccination of health care workers in nursing homes: insights from a mathematical model. PLoS Med. 2008;5:e200.
86. van den Dool C, Bonten MJ, Hak E, Wallinga J. Modeling the effects of influenza vaccination of health care workers in hospital departments. Vaccine. 2009;27:6261-6267.
87. Wendelboe AM, Grafe C, McCumber M, Anderson MP. Inducing herd immunity against seasonal influenza in long-term care facilities through employee vaccination coverage: a transmission dynamics model. Comput Math Methods Med. 2015;2015:178247.
88. Demicheli V, Jefferson T, Al-Ansary LA, et al. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 2014(3):Cd001269.
89. Ng AN, Lai CK. Effectiveness of seasonal influenza vaccination in healthcare workers: a systematic review. J Hosp Infect. 2011;79:279-286.
90. Daugherty JD, Blake SC, Grosholz JM, et al. Influenza vaccination rates and beliefs about vaccination among nursing home employees. Am J Infect Control. 2015;43:100-106.
91. Black CL, Yue X, Ball SW, et al. Influenza vaccination coverage among health care personnel – United States, 2015-16 influenza season. MMWR Morb Mortal Wkly Rep. 2016;65:1026-1031.
92. Hollmeyer HG, Hayden F, Poland G, Buchholz U. Influenza vaccination of health care workers in hospitals–a review of studies on attitudes and predictors. Vaccine. 2009;27:3935-3944.
93. Babcock HM, Gemeinhart N, Jones M, Dunagan WC, Woeltje KF. Mandatory influenza vaccination of health care workers: translating policy to practice. Clin Infect Dis. 2010;50:459-464.
94. Hollmeyer H, Hayden F, Mounts A, Buchholz U. Review: interventions to increase influenza vaccination among healthcare workers in hospitals. Influenza Other Respir Viruses. 2013;7:604-621.
95. Tailoring Immunization Programmes for Seasonal Influenza (TIP FLU). A guide for increasing health care workers’ uptake of seasonal influenza vaccination. Available from: http://www.euro.who.int/__data/assets/pdf_file/0007/290851/TIPGUIDEFINAL.pdf?ua=1. Accessed January 1, 2017.
96. Tailoring Immunization Programmes for Seasonal Influenza (TIP FLU). Understanding health care workers’ uptake of seasonal influenza vaccination in Montenegro: a case study for policy-makers and programme managers (2015). Available from: http://www.euro.who.int/__data/assets/pdf_file/0007/281860/Tailoring-Immunization-Programmes-Seasonal-Influenza-TIP-FLU.pdf?ua=1. Accessed January 1, 2017
97. Falsey AR, Baran A, Walsh EE. Should clinical case definitions of influenza in hospitalized older adults include fever? Influenza Other Respir Viruses. 2015;9(suppl 1):23-29.
98. Sayers G, Igoe D, Carr M, et al. High morbidity and mortality associated with an outbreak of influenza A(H3N2) in a psycho-geriatric facility. Epidemiol Infect. 2013;141:357-365.
99. Mahmud SM, Thompson LH, Nowicki DL, Plourde PJ. Outbreaks of influenza-like illness in long-term care facilities in Winnipeg, Canada. Influenza Other Respir Viruses. 2013;7:1055-1061.
100. Global Epidemiological Surveillance Standards for Influenza. Geneva: WHO; 2013. Available from: http://www.who.int/influenza/resources/documents/WHO_Epidemiological_Influenza_Surveillance_Standards_2014.pdf?ua=1. Accessed June 23, 2016.
101. European Centre for Disease Prevention and Control (ECDC). Influenza Case Definitions. Stockholm: ECDC. Available from: http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32012D0506&qid=1428573336660&from=EN#page=16 Accessed December 12, 2016.
102. World Health Organization. WHO recommendations on the use of rapid testing for influenza diagnosis. Available from: http://www.who.int/influenza/resources/documents/RapidTestInfluenza_WebVersion.pdf. Accessed November 23, 2016.
103. Chartrand C, Leeflang MM, Minion J, Brewer T, Pai M. Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann Intern Med. 2012;156:500-511.
104. Infection Prevention and Control of Epidemic- and Pandemic-Prone Acute Respiratory Infections in Health Care. Geneva: World Health Organization; 2014. Available from: https://www.ncbi.nlm.nih.gov/books/NBK214350/. Accessed January 10, 2017.
105. Jefferson T, Del Mar C, Dooley L, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev. 2010(1):Cd006207.
106. Wong VW, Cowling BJ, Aiello AE. Hand hygiene and risk of influenza virus infections in the community: a systematic review and meta-analysis. Epidemiol Infect. 2014;142:922-932.
107. Rainwater-Lovett K, Chun K, Lessler J. Influenza outbreak control practices and the effectiveness of interventions in long-term care facilities: a systematic review. Influenza Other Respir Viruses. 2014;8:74-82.
108. Cowling BJ, Zhou Y, Ip DK, Leung GM, Aiello AE. Face masks to prevent transmission of influenza virus: a systematic review. Epidemiol Infect. 2010;138:449-456.
109. bin-Reza F, Lopez Chavarrias V, Nicoll A, Chamberland ME. The use of masks and respirators to prevent transmission of influenza: a systematic review of the scientific evidence. Influenza Other Respir Viruses. 2012;6:257-267.
110. Drinka PJ, Krause PF, Nest LJ, Goodman BM, Gravenstein S. Risk of acquiring influenza B in a nursing home from a culture-positive roommate. J Am Geriatr Soc. 2005;53:1437.
111. Otter JA, Donskey C, Yezli S, et al. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. J Hosp Infect. 2016;92:235-250.
112. Greatorex JS, Page RF, Curran MD, et al. Effectiveness of common household cleaning agents in reducing the viability of human influenza A/H1N1. PLoS One. 2010;5:e8987.
113. Kelly H, Cowling BJ. Influenza: the rational use of oseltamivir. Lancet. 2015;385:1700-1702.
114. Jefferson T, Jones MA, Doshi P, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2014(4):Cd008965.
115. Dobson J, Whitley RJ, Pocock S, Monto AS. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet. 2015;385:1729-1737.
116. Burch J, Paulden M, Conti S, et al. Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation. Health Technol Assess. 2009;13:1-265, iii-iv.
117. Hsu J, Santesso N, Mustafa R, et al. Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies. Ann Intern Med. 2012;156:512-524.
118. Burch J, Corbett M, Stock C, et al. Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis. Lancet Infect Dis. 2009;9:537-545.
119. Muthuri SG, Venkatesan S, Myles PR, et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med. 2014;2:395-404.
120. European Centre for Disease Prevention and Control (ECDC). ECDC preliminary scientific advice. Expert opinion in neuraminidase inhibitors for prevention and treatment of influenza. Available from: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/neuraminidase-inhibitors-flu-consultation.pdf. November 24, 2016.
121. Wellcome Trust Academy of Medical Sciences. Use of neuraminidase inhibitors in influenza. October 2015. Available from: https://www.acmedsci.ac.uk/viewFile/561595082cd83.pdf. Accessed November 24, 2016.
122. Okoli GN, Otete HE, Beck CR, Nguyen-Van-Tam JS. Use of neuraminidase inhibitors for rapid containment of influenza: a systematic review and meta-analysis of individual and household transmission studies. PLoS One. 2014;9:e113633.
123. Peters PH Jr, Gravenstein S, Norwood P, et al. Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population. J Am Geriatr Soc. 2001;49:1025-1031.
124. Ambrozaitis A, Gravenstein S, van Essen GA, et al. Inhaled zanamivir versus placebo for the prevention of influenza outbreaks in an unvaccinated long-term care population. J Am Med Dir Assoc. 2005;6:367-374.
125. LaForce C, Man CY, Henderson FW, et al. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial. Clin Ther. 2007;29:1579-1590; discussion 7-8.
126. Penttinen P, Catchpole M. ECDC expert opinion on efficacy and effectiveness of neuraminidase inhibitors published for public consultation. Influenza Other Respir Viruses. 2016;10:152-153.